01 1ACETAMINOPHEN; BUTALBITAL; CAFFEINE
02 1ACETAMINOPHEN; CODEINE PHOSPHATE
03 2ACETAMINOPHEN; HYDROCODONE BITARTRATE
04 2AMCINONIDE
05 1ASPIRIN; CARISOPRODOL
06 1ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE
07 2ASPIRIN; OMEPRAZOLE
08 2CARBINOXAMINE MALEATE
09 2CHLORPROMAZINE HYDROCHLORIDE
10 2CLEMASTINE FUMARATE
11 1CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
12 1DESONIDE
13 3HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
14 1HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE
15 4HYDROMORPHONE HYDROCHLORIDE
16 2INDOMETHACIN
17 2ISONIAZID
18 2ISOSORBIDE MONONITRATE
19 12LEVOTHYROXINE SODIUM
20 4MEPERIDINE HYDROCHLORIDE
21 1METOCLOPRAMIDE HYDROCHLORIDE
22 2MORPHINE SULFATE
23 1NYSTATIN
24 3OXYCODONE HYDROCHLORIDE
25 1PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
26 7POTASSIUM CHLORIDE
27 1PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM
01 1AEROSOL, FOAM;TOPICAL
02 1AEROSOL, METERED;TOPICAL
03 3CAPSULE;ORAL
04 2CONCENTRATE;ORAL
05 1CREAM;TOPICAL
06 4FOR SOLUTION;ORAL
07 1OINTMENT;TOPICAL
08 1SOLUTION/DROPS;OPHTHALMIC
09 12SOLUTION;ORAL
10 1SUSPENSION;ORAL
11 5SYRUP;ORAL
12 2TABLET, DELAYED RELEASE;ORAL
13 30TABLET;ORAL
01 10.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
02 10.05%
03 10.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
04 10.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
05 10.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
06 20.1%
07 10.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
08 10.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
09 10.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
10 10.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
11 10.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
12 10.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
13 10.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
14 10.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
15 11%;1%
16 21.5MG/5ML;5MG/5ML
17 11.5MG;5MG
18 1100,000 UNITS/ML
19 2100MG
20 1100MG/5ML
21 1100MG/ML
22 110MEQ
23 110MEQ/15ML
24 110MG
25 110MG/5ML;5MG/5ML;6.25MG/5ML
26 1120MG/5ML;12MG/5ML
27 1150MG
28 115MEQ
29 115MG
30 12.68MG
31 120MEQ
32 120MEQ/15ML
33 220MG
34 12MG
35 1300MG
36 130MG
37 130MG/ML
38 1325MG/15ML;50MG/15ML;40MG/15ML
39 2325MG/15ML;7.5MG/15ML
40 1325MG;200MG
41 1325MG;200MG;16MG
42 1325MG;40MG
43 140MEQ
44 140MEQ/15ML
45 140MG
46 24MG
47 14MG/5ML
48 150MG
49 15MG
50 25MG/5ML
51 15MG/5ML;6.25MG/5ML
52 175MG
53 181MG;40MG
54 18MG
55 1EQ 0.23% PHOSPHATE;10%
56 1EQ 0.5MG BASE/5ML
57 1EQ 5MG BASE/5ML
01 22DISCN
02 42RX
RLD : No
TE Code :
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Dosage Form : SOLUTION; ORAL
Proprietary Name : BUTALBITAL, ACETAMINOPHE...
Dosage Strength : 325MG/15ML;50MG/15ML;40M...
Approval Date : 2003-01-31
Application Number : 40387
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code :
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form : SOLUTION; ORAL
Proprietary Name : ACETAMINOPHEN AND CODEIN...
Dosage Strength : 120MG/5ML;12MG/5ML
Approval Date : 1982-01-01
Application Number : 87508
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code : AA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Dosage Form : SOLUTION; ORAL
Proprietary Name : HYDROCODONE BITARTRATE A...
Dosage Strength : 325MG/15ML;7.5MG/15ML
Approval Date : 2011-07-19
Application Number : 40894
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code :
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Dosage Form : SOLUTION; ORAL
Proprietary Name : HYDROCODONE BITARTRATE A...
Dosage Strength : 325MG/15ML;7.5MG/15ML
Approval Date : 2012-01-25
Application Number : 200343
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
Dosage Form : CREAM; TOPICAL
Proprietary Name : AMCINONIDE
Dosage Strength : 0.1%
Approval Date : 2003-05-15
Application Number : 76065
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Dosage Form : OINTMENT; TOPICAL
Proprietary Name : AMCINONIDE
Dosage Strength : 0.1%
Approval Date : 2002-11-19
Application Number : 76096
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : CARISOPRODOL AND ASPIRIN
Dosage Strength : 325MG;200MG
Approval Date : 1996-04-25
Application Number : 40116
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE
Dosage Form : TABLET; ORAL
Proprietary Name : CARISOPRODOL, ASPIRIN AN...
Dosage Strength : 325MG;200MG;16MG
Approval Date : 2010-01-07
Application Number : 40860
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Proprietary Name : YOSPRALA
Dosage Strength : 81MG;40MG
Approval Date : 2016-09-14
Application Number : 205103
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Proprietary Name : YOSPRALA
Dosage Strength : 325MG;40MG
Approval Date : 2016-09-14
Application Number : 205103
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
Genus Lifesciences is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find Indomethacin bulk offered by Genus Lifesciences
